Main
>
ENDOCRINOLOGY
>
Diabetes. Treatment
>
SitaGliptin (DPP-IV Inhibitor)
>
Co.: USA. M. (Brand/Tablet/Patents)
>
Patent>US Expiration: 07.05.2022
Patent>US Expiration: 07.05.2022's products
This section has no products